Skip to main content
SpringerLink
Log in

Surgical therapy and empirical antibacterials are sufficient in most patients with complicated intra-abdominal infections

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV

References

  1. Blot S, De Waele JJ. Critical issues in the clinical management of complicated intra-abdominal infections. Drugs 2005; 65(12): 1611–20

    Article  PubMed  Google Scholar 

  2. Mazuski JE, Sawyer RG, Nathens AB, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) 2002; 3: 161–73

    Article  Google Scholar 

  3. Solomkin JS, Mazuski JE, Baron EJ, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 2003; 37: 997–1005

    Article  PubMed  Google Scholar 

  4. Kirton OC, O’Neill PA, Kestner M, et al. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days. J Trauma 2000; 49: 822–32

    Article  PubMed  CAS  Google Scholar 

  5. Dougherty SH. Antimicrobial culture and susceptibility testing has little value for routine management of secondary bacterial peritonitis. Clin Infect Dis 1997; 25Suppl. 2: S258–61

    Article  PubMed  Google Scholar 

  6. Mosdell DM, Morris DM, Voltura A, et al. Antibiotic treatment for surgical peritonitis. Ann Surg 1991; 214: 543–9

    Article  PubMed  CAS  Google Scholar 

  7. Schein M, Marshall J. Source control: a guide to the management of surgical infections. Heidelberg: Springer Verlag, 2002

    Google Scholar 

  8. Wittmann DH, Schein M, Condon RE. Management of secondary peritonitis. Ann Surg 1996; 224: 10–8

    Article  PubMed  CAS  Google Scholar 

  9. Hartstein AI, Mulligan ME, Morthland VH, et al. Recurrent Staph-ylococcus aureus bacteremia. J Clin Microbiol 1992; 30: 670–4

    PubMed  CAS  Google Scholar 

  10. De Waele JJ, Vogelaers D, Hoste E, et al. Emergence of antibiotic resistance in infected pancreatic necrosis. Arch Surg 2004; 139: 1371–5

    Article  PubMed  Google Scholar 

  11. Blot S, Vandewoude K. Early detection of systemic infection. Acta Clin Belg 2004; 59: 20–3

    PubMed  CAS  Google Scholar 

  12. Carmeli Y, Troillet N, Karchmer AW, et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999; 159: 1127–32

    Article  PubMed  CAS  Google Scholar 

  13. Blot S, Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 2004; 64: 2159–75

    Article  PubMed  CAS  Google Scholar 

  14. Eggimann P, Francioli P, Bille J, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27: 1066–72

    Article  PubMed  CAS  Google Scholar 

  15. Oude Lashof AM, Donnelly JP, Meis JF, et al. Duration of antifungal treatment and development of delayed complications in patients with candidaemia. Eur J Clin Microbiol Infect Dis 2003; 22: 43–8

    PubMed  CAS  Google Scholar 

  16. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31Suppl. 4: S131–8

    Article  PubMed  Google Scholar 

  17. Kollef M. Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. Drugs 2003; 63: 2157–68

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Surgical therapy and empirical antibacterials are sufficient in most patients with complicated intra-abdominal infections. Drugs Ther. Perspect 22, 8–11 (2006). https://doi.org/10.2165/00042310-200622070-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622070-00003

Search

Navigation